ROBICHAUD ALBERT (Chief Scientific Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/17/2021ACC: 0001562180-21-004339
Officer· Chief Scientific Officer
Since Dec 2018
+2.86K
Net shares
Net buyer
$67.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
4K acquired · 1.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4K
Price / share
—
Trade value
—
% of position
2.9%
6/15/2021
136.79K→140.79K
Common Stock
Direct
Shares
−1.14K
Price / share
$58.80
Trade value
$67.27K
% of position
0.8%
6/15/2021
140.79K→139.65K
Total
Net shares
+2.86K
Net value
-$67.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2021 | A · Award | +4K | — | — | 2.9% | 136.79K | 140.79K |
| Common Stock Direct | 6/15/2021 | F · Tax Withholding | −1.14K | $58.80 | $67.27K | 0.8% | 140.79K | 139.65K |
| Total | +2.86K | -$67.27K | ||||||
Derivative Transactions0
No derivative transactions reported